Search for Biomarkers Crucial to Neurodegenerative Disease Therapeutics and Diagnostics

Search for Biomarkers Crucial to Neurodegenerative Disease Therapeutics and Diagnostics

Kalorama Information offers related market research titles with Proteomics Markets (research and clinical markets ), Proteomics Research Markets and The Global Market for Biomarkers.

The debilitating neurodegenerative diseases Alzheimer’s and Parkinson’s have vexed healthcare in terms of both therapy and definitive antemortem diagnosis. The localized nature of the diseases in the central nervous system (CNS) makes the development of in vitro diagnostic (IVD) tests difficult. An incomplete unde...


Critical Insights into IVD Market-Driving Segments - Kalorama’s Latest Reports in Cancer, Molecular and Infectious Disease Diagnostics

Critical Insights into IVD Market-Driving Segments - Kalorama’s Latest Reports in Cancer, Molecular and Infectious Disease Diagnostics

Kalorama Information’s latest in vitro diagnostics (IVD) titles delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics, molecular assays and systems, and infectious disease tests. Together, these three IVD areas represent approximately 40% of the overall IVD market. The rate of growth for the combined segments is outpacing the growth of the overall IVD market by roughly two extra percentage points each year (+2% CAGR). Several subsegments of th...


Top Infectious Diseases in the IVD Market - Hepatitis

Top Infectious Diseases in the IVD Market - Hepatitis

The following analysis is derived from Kalorama Information’s recently released global market research report: The Worldwide Market for Infectious Disease Diagnostic Tests.

This is the third in a series of five posts outlining the leading infectious diseases or infectious disease groups in terms of IVD market sales. Previous posts were for HIV/AIDS and respiratory tract infection tests.

Tests for viral hepatitis infections, primarily hepatitis C virus (HCV) and hepatitis B virus (HBV), are a...


QIAGEN Bolsters Presence in Clinical NGS and Cancer Diagnostics Markets with GeneReader System Launch

QIAGEN Bolsters Presence in Clinical NGS and Cancer Diagnostics Markets with GeneReader System Launch

Kalorama Information provides further analysis of QIAGEN and its competitors, including the companies’ cancer diagnostics and NGS product portfolios, in recent market research reports The World Market for Cancer Diagnostics, 6 th Edition ; Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets ; and Next Generation Sequencing Markets.

Several years of technology acquisition and internal development have culminated for QIAGEN with the launch of its comprehensiv...